Author

Yi-Dan Lin

h-index 23 View on Semantic Scholar

We have 2 of 122 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

IGF2BP3 promotes esophageal squamous cell carcinoma progression by regulating global protein translation.

It is found that IGF2BP3 was upregulated in ESCC tissues, and elevated IGF2BP3 expression correlates with reduced overall survival and is highlighted as a promising molecular target for further therapeutic exploration in ESCC.

Gu-Ha A-Lai, Shuangyan Tan, Wen-Rong Liu et al. · Biochimica et Biophysica Act... · 0 citations

Review Open access Aug 2026

Advances in understanding the mechanisms underlying acquired resistance to third-generation tyrosine kinase inhibitors in non-small cell lung cancer

The persistent emergence of resistance underscores that current targeted therapies, while revolutionary, are primarily disease-modifying rather than curative, necessitating continuous innovation to overcome the inherent biological challenge of tumor adaptability and heterogeneity.

Gu-Ha A-Lai, Lian Li, G. Ma et al. · Frontiers in Cell and Develo... · 0 citations